Human genetic analysis found that rare and common coding variants in the MMP9 gene are associated with neuropathic pain ...

Researchers show mutant NRAS and wild-type HRAS cooperate in cancer signaling, pointing to mutation-guided combination ...

Transgene, based in France, is focused on the design and development of immunotherapies for the treatment of cancer.

Researchers hope that the study could lead to new osteoporosis treatments that tackle bone loss and address some of the wider ...

RNAV8 will be part of a team led by the Rouskin Lab at Harvard Medical School with the Weissman Lab at MIT/the Whitehead ...

A secured bioinformatics backbone, the most critical part of next-generation sequencing, means reliable, auditable data handling.

The funds will support efforts to advance its lead candidate into human clinical trials in 2027, and expand its pipeline of ...

BrainChild Bio has raised a $116 million Series A financing, the proceeds of which will, in part, fund the pivotal ...

Novartis has acknowledged that its neuromuscular candidate delpacibart etedesiran (del-desiran) failed a pivotal Phase III ...

Gene therapy will not reach its full potential as a transformative treatment for genetic diseases unless manufacturing ...

Medicines Discovery Catapult (MDC) says it is a life sciences service dedicated to turning drug discovery into commercial breakthroughs.

Experiments revealed the profound influence of microenvironmental context on uropathogenic E. coli infection dynamics and ...